AstraZeneca opened its global headquarters and research and discovery centre at the £1billion Discovery Centre (the DISC) on ...

A review of the last 10 years of partnership focusing on scientific collaboration, nurturing talent and strengthening our ecosystem.

The company will build a multi-billion-dollar drug manufacturing center in Virginia that will focus on chronic diseases, as ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

AstraZeneca (Cambridge, U.K.) announced $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines ...

The U.K. biopharmaceutical giant’s plans include a proposal for a new drug substance manufacturing center focused on ...

Cambridge life science neighbours Sortera Bio and AstraZeneca have added extra oomph to their fledgling partnership. In terms ...

AstraZeneca plans to construct a multi-billion dollar manufacturing center focused on chronic diseases in Virginia within the next five years.

AstraZeneca <AZN.L> is closing in on a site for its new $500 million home in Cambridge, with a biomedical park just south of the English city the most likely site, property industry sources ...

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.